Tissue Regenix Group plc (LON:TRX – Get Free Report) shares hit a new 52-week low on Friday . The stock traded as low as GBX 35 ($0.45) and last traded at GBX 35 ($0.45), with a volume of 22314 shares traded. The stock had previously closed at GBX 36.50 ($0.47).
Tissue Regenix Group Price Performance
The firm has a market cap of £31.55 million, a PE ratio of -36.13 and a beta of 1.61. The stock has a 50 day simple moving average of GBX 46.41 and a two-hundred day simple moving average of GBX 53.54. The company has a debt-to-equity ratio of 31.16, a quick ratio of 2.36 and a current ratio of 4.03.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Recommended Stories
- Five stocks we like better than Tissue Regenix Group
- Where Do I Find 52-Week Highs and Lows?
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Disney 2025 Shareholders: Major Updates for Investors
- Golden Cross Stocks: Pattern, Examples and Charts
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
